Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
tadalafil/dutasteride (DKF-313) / Dongkook Pharma
DKF-313-P3, NCT04947631: Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia	Completed	3	667	RoW	DKF-313, Dutasteride, Avodart, Tadalafil, Cialis, DKF-313 placebo, Dutasteride placebo, Tadalafil placebo	Dongkook Pharmaceutical Co., Ltd.	Benign Prostatic Hyperplasia	06/23	06/23